Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.63 |
| ▸ | CALCRL | Q16602 | 4/20 | 0.52 |
| ▸ | REN | P00797 | 3/20 | 0.51 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.50 |
| ▸ | CMA1 | P23946 | 1/20 | 0.49 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30094362 | 0.94 | SLC6A2 (0.54) | SLC6A2RENCMA1 | |
| SCHEMBL30059762 | 0.92 | SLC6A2 (0.50) | SLC6A2CALCRLNTSR1BACE1 | |
| SCHEMBL30690065 | 0.90 | SLC6A2 (0.59) | SLC6A2CALCRLNTSR1 | |
| SCHEMBL31151838 | 0.89 | SLC6A2 (0.73) | SLC6A2CALCRLREN | |
| SCHEMBL29616319 | 0.88 | SLC6A2 (0.53) | SLC6A2REN | |
| SCHEMBL38665591 | 0.88 | SLC6A2 (0.59) | SLC6A2CALCRLNTSR1BACE1 | |
| SCHEMBL30974085 | 0.88 | NTSR1 (0.53) | SLC6A2CALCRLNTSR1KEAP1 | |
| SCHEMBL31247408 | 0.86 | SLC6A2 (0.55) | SLC6A2CALCRLNTSR1KEAP1 | |
| SCHEMBL8142396 | 0.85 | BACE1 (0.49) | CALCRLRENBACE1 | |
| SCHEMBL30412382 | 0.85 | OPRM1 (0.54) | SLC6A2REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240317826-A1 | COMPOSITIONS AND METHODS FOR TREATING AND/OR IDENTIFYING AN AGENT FOR TREATING HIV-1 INFECTIONS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-09-26 | — | — | US | claimed |
| WO-2022240959-A2 | COMPOSITIONS AND METHODS FOR TREATING AND/OR IDENTIFYING AN AGENT FOR TREATING HIV-1 INFECTIONS | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2022-11-17 | — | — | WO | claimed |
| US-20240317826-A1 | COMPOSITIONS AND METHODS FOR TREATING AND/OR IDENTIFYING AN AGENT FOR TREATING HIV-1 INFECTIONS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-09-26 | — | — | US | disclosed |
| WO-2022240959-A2 | COMPOSITIONS AND METHODS FOR TREATING AND/OR IDENTIFYING AN AGENT FOR TREATING HIV-1 INFECTIONS | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2022-11-17 | — | — | WO | disclosed |